Press Releases

Print

Members of the DEGRO working group Students/Club 100 visit Eckert & Ziegler BEBIG production

Seneffe, Belgium, November 1, 2017. On Friday, medical students of the working group Students/Club 100 of the German Society for Radiation Oncology (DEGRO) were invited to visit the IsoSeed® I-125 production facility at Eckert & Ziegler BEBIG in Berlin, Germany. The group, interested in radiotherapy, was accompanied by Professor Franz-Josef Prott, radiotherapist at St. Josefs-Hospital in Wiesbaden, Germany, and chairman of the working group as well as Professor Haverkamp, leading physicist of the Clinic for Radiation Therapy in the University Hospital Münster.

Dr. Hasselmann, Managing Director of Eckert & Ziegler BEBIG and Member of the Board of Directors of Eckert & Ziegler AG, left, and Eckert & Ziegler BEBIG employees say goodbye to the DEGRO working group Students/Club 100

During the guided tour, the students were shown the different steps of the automatic I-125 seed production, with its high-quality requirements and radiation protection standards. This includes the insertion of the IsoSeed® activity carrier into the titanium capsule, followed by the laser welding and leakage test, as well as the verification of the activity and the source anisotropy that are carried out as the final production steps.

In addition, Eckert & Ziegler BEBIG representatives gave an excursus regarding permanent (LDR implantation) and temporary (HDR afterloading) brachytherapy techniques, scope of application and a hands-on workshop with IsoSeed® dummies and HDR applicators. "The aim of this visit was to introduce the students to brachytherapy as an integral part of radiation therapy for the treatment of many tumor sites. Visiting a production site and getting insights from an established brachytherapy provider was a well perceived addition to regular classes", states Professor Prott.

About Eckert & Ziegler BEBIG
Contributing to saving lives!
Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treat­ment of cancer using brachytherapy. The company's headquarters are in Belgium, with production facilities in Germany and in the USA, as well as subsidiaries throughout Europe, the USA and Brazil. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing and distribution of its product line. The company's products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists.
Eckert & Ziegler BEBIG employs approximately 130 people. The company has been listed on the Euronext stock exchange since April 1997.

About the working group Students/Club 100 of the German Society for Radiation Oncology (DEGRO)
Since 2011, the German Society for Radiation Oncology has been actively involved in the promotion of young researchers and regularly invites students who are interested in this subject area to the DEGRO Annual Meeting. In the meantime, approximately 120 medical students have become members of the Club 100 and at least 15 radiation therapists have emerged from the group.
In order to substantiate the activities, on June 6, 2012, Students/Club 100 was established as a working group of DEGRO by decision of the Board of Directors.

Contact:
Annica Witt
Marketing Communication Manager
marketing@bebig.com
www.bebig.com

Back